As the direct cytotoxic killing of superantigen-coated tumor cells is predominantly executed by Vβ3 CD8+ T cells [10], these data suggest that TCR Vβ3 CD8+ effector T cells egressed from the TDLNs into the tumor. The gene discussed is CD8A; the disease is neoplasm.